Current Clinical Research Projects at Our Clinic
ONO Pharmaceutical Co., Ltd.
Protocol: ONO-2020-02
Patients: 55-85 years old
Diagnostic: Mild-Moderate AD
Agent: ONO-2020
Daily Oral Administration
Enrollment: Open
Actinogen Medical Ltd.
Protocol: ACW0009
Patients: 50+ years old
Diagnostic: Mild-Moderate AD
Agent: UE2343
Daily Oral Administration
Enrollment: Open
AriBio Co. Ltd.
Protocol: AR1001-ADP3-US01
Patients: 55-90 years old
Diagnostic: Early AD
Agent: AR1001
Daily Oral Administration
Enrollment: Closed
Cognito Therapeutics, Inc.
Protocol: CA-0011
Patients: 50-90 years old
Diagnostic: Mild-Moderate AD
Agent: Medical Device
Worn Daily for 1 Hour
Enrollment: Closed
Alzheon Inc.
Protocol: ALZ-801-AD301
Patients: 50-80 years old
Diagnostic: Early AD
Agent: ALZ-801
Twice Daily Oral Administration
Enrollment: Closed
Eli Lilly and Company
Protocol: I5T-MC-AACM
Patients: 65-80 years old
Diagnostic: Prodromal/Asymptomatic AD
Agent: Donanemab
Intravenous Administration Every 4 Weeks
Enrollment: Closed